Highmark medical policy is intended to serve only as a general reference resource regarding coverage for the services described. This policy does not constitute medical advice and is not intended to govern or otherwise influence medical decisions.
This policy provides information regarding the coverage of, as determined by applicable federal and/or state legislation.
This policy is designed to address medical necessity guidelines that are appropriate for the majority of individuals with a particular disease, illness or condition. Each person’s unique clinical circumstances warrant individual consideration, based upon review of applicable medical records.
The qualifications of the policy will meet the standards of the National Committee for Quality Assurance (NCQA) and the Delaware Department of Health and Social Services (DHSS) and all applicable state and federal regulations.
This medical policy outlines Highmark Health Options Duals services for Peripheral Nerve Stimulation.
Highmark Health Options Duals (HHO Duals) – Highmark Health Options Duals is designed for people with both Medicare and Medicaid. Our D-SNP Medicare Advantage HMO coverage offers the same benefits as Original Medicare, plus extra benefits, like prescription drug coverage and vision and dental care.
Prior authorization is required.
Please review the specific National Coverage Determination (NCD), Local Coverage Determination (LCD) and/or Local Coverage Article (LCA) information, as well as other CMS sources, using the links below.
Post-payment Audit Statement
The medical record must include documentation that reflects the medical necessity criteria and is subject to audit by HHO Duals at any time pursuant to the terms of your provider agreement.
Place of Service
Please refer to the NCD, LCD, LCA, or CMS guidelines for the place of service for peripheral nerve stimulation.
Coverage Determination and Links
HHO Duals follows the coverage determinations made by CMS as outlined in either the NCD or the state-specific LCD/LCA.
CMS Link
NCD/LCD Links
· There are no specific NCDs related to this topic. There are two related NCDS:
o NCD: Electrical Nerve Stimulators (160.7)
o NCD: Assessing Patient's Suitability for Electrical Nerve Stimulation Therapy (160.7.1)
· LCD: Peripheral Nerve Stimulation (L37360)
Article Link
· LCA: Billing and Coding: Peripheral Nerve Stimulation (A55531)
Reimbursement
Participating facilities will be reimbursed per their HHO Duals contract.
Centers for Medicare and Medicaid Services (CMS). National Coverage Determination (NCD) Electrical Nerve Stimulators (160.7). Effective date August 7, 1995. Accessed on December 28, 2023.
Centers for Medicare and Medicaid Services (CMS).National Coverage Determination (NCD) Assessing Patient's Suitability for Electrical Nerve Stimulation Therapy (106.7.1). Effective date June 19, 2006. Implementation date June 19, 2006. Accessed on December 28, 2023.
Centers for Medicare and Medicaid Services (CMS). Local Coverage Determination (LCD) Peripheral Nerve Stimulation (L37360). Original Effective date August 27, 2018. Revision Effective date December 1, 2019. Accessed on December 28, 2023.
Centers for Medicare and Medicaid Services (CMS).Local Coverage Article Billing and Coding: Peripheral Nerve Stimulation (A55531). Original Effective date August 27, 2018. Revision Effective date January 1, 2024. Accessed on December 28, 2023.
For questions related to this policy, contact the Highmark Government Market Policy Team at GovernmentPolicy@Highmark.com